Category Archives: People

Megan Bailey joins the Novo Holdings Advisory Group

Novo Holdings

Novo Holdings is pleased to announce the appointment of Megan Bailey, CEO of Personal Genome Diagnostics (PGDx), to the Novo Advisory Group (NAG) – an expert panel of senior industry leaders that supports Novo Holdings in analysing and monitoring its larger life science investments.

Kasim Kutay, CEO of Novo Holdings, said: “With a track record at the intersection of personalised medicine, diagnostics, and health care IT, Megan brings a strong understanding to the NAG of some of the most important convergence trends in the world of healthcare. I am delighted to welcome Megan to the NAG and very much look forward to her contributions.”

Megan Bailey has over 19 years of leadership experience in the healthcare industry. Before becoming CEO of PGDx, she served as the company’s Chief Commercial Officer, leading the marketing, sales, and customer support teams. Before that, Megan was Vice President, Marketing. PGDx was founded in 2010 to help bring novel genomic diagnostic approaches to patients with cancer.

Prior to joining PGDx in 2018, Megan had held several senior commercial roles at diagnostics company Ventana Medical Systems and subsequently at Roche.

Megan Bailey said: “It is an honour to join this group of extraordinary industry leaders and a team of people so committed to impacting health, science, and society in a meaningful way, and I look forward to contributing to this noble mission.”

About Megan Bailey

American citizen

Career

2020 – CEO, PDGx

2018 – 2020: Various roles with PDGx, including Chief Commercial
Officer and Vice President, Marketing

2016 – 2018: Senior Director, Sales, Roche

2012 – 2015: Group Marketing Manager, Roche

2008 – 2012: Various positions at Ventana Medical Systems, including Senior International Product Manager

Current board positions
Megan serves on the UMB Foundation Board of Trustees and the Army West Point Athletic Association Board of Directors.

Education
Megan is a graduate of the United States Military Academy at West Point and earned her Master of Public Health from the University of North Carolina – Chapel Hill.

About Novo Holdings A/S

Novo Holdings A/S is a private limited liability company wholly owned by the Novo Nordisk Foundation. It is the holding company of the Novo Group, comprising Novo Nordisk A/S and Novozymes A/S, and is responsible for managing the Novo Nordisk Foundation’s assets.

Novo Holdings is recognized as a leading international life science investor, with a focus on creating long-term value. As a life science investor, Novo Holdings provides seed and venture capital to development-stage companies and takes significant ownership positions in growth and well-established companies. Novo Holdings also manages a broad portfolio of diversified financial assets.

Further information

Marie-Louise Jersin, Senior Communications Partner, +45 3049 4957, maj@novo.dk

Categories: People

Mountaingate Capital Promotes Trent Sisson to Managing Director

Mountaingate

DENVER, Colo., May 6, 2022 – Mountaingate Capital announced the promotion of Trent Sisson to Managing Director and Partner. He will join the founding Partners working together to continue the firm’s mission of investing behind founder, owner-entrepreneurs to rapidly scale companies.

“We are thrilled to make this announcement. We first began working with Trent over 12 years ago and since rejoining our team in 2017, Trent has made a tremendous impact at our firm as well as across numerous portfolio company investments.  Trent brings practical operating experience and market insights coupled with strong investment acumen that is invaluable.  More importantly, he is committed to supporting our portfolio company management teams and is an enthusiastic leader within the firm.” commented Bennett Thompson, Co-Founder and Managing Director.

Mr. Sisson first worked with the Mountaingate founding team at their predecessor firm, KRG Capital Partners, before completing his M.B.A. at Columbia Business School and subsequently spending time in operational roles at PepsiCo and Sprinklr. He joined Mountaingate in 2017 in conjunction with the final close of Mountaingate Fund I.

About Mountaingate Capital

Mountaingate Capital, a Denver-based private equity firm investing in the marketing services, business services, specialty distribution and specialty manufacturing sectors. Mountaingate specializes in building and empowering companies with strong growth potential and engaged leadership teams and has been honored for three consecutive years by Inc. Magazine as one of the most founder friendly private equity firms. Mountaingate’s focus on organic growth coupled with its proven customer-centric buy-and-build approach and shared equity ownership with management creates more value for the end customer, while forging stronger, more collaborative, and more successful partnerships with management teams. Mountaingate targets investments in new platform companies with $5 million to $25 million of EBITDA, as well as add-on acquisitions of any size. For more information on Mountaingate, please visit www.mountaingate.com.

Contact

Bennett Thompson, Managing Director

303-390-5001

Categories: People

Brooks Entwistle proposed as new Board member of EQT AB

eqt

EQT AB (publ) today announced that the nomination committee proposes Brooks Entwistle as Board member in EQT AB, bringing a broad experience from the global capital markets and the tech industry.

Brooks Entwistle is currently SVP of Global Customer Success at blockchain company Ripple and has a vast experience from leading positions in both tech and financial markets throughout the APAC region, spanning over 30 years. Prior to joining Ripple, Brooks Entwistle served as Chief Business Officer International for Uber, responsible for business development and the firm’s relationships across Asia Pacific, EMEA and Latin America. Among previous experiences, he spent 22 years at Goldman Sachs in various capacities, including as Partner CEO of Goldman Sachs India, Goldman Sachs South East Asia, as well as CEO of Goldman Sachs Singapore.

Jacob Wallenberg, Chairperson of the nomination committee, comments, “Brooks Entwistle’s collective experience and expertise from the international tech scene and global capital markets will add vital perspectives to EQT’s growth agenda, especially with the added focus on Asia and the combination with BPEA.”

Edith Cooper has declined re-election, after serving on the Board for four years. Conni Jonsson, Chairperson of the EQT AB Board, comments, “Edith is a true challenger who has built awareness around various topics, including diversity and inclusion, and she established and developed the Remuneration Committee under a period of rapid growth. I’m very grateful for Edith’s contributions, especially during the IPO process. Her vast experience and commitment to the Board has been invaluable.”

The nomination committee’s complete proposals to EQT AB’s Annual Shareholders’ Meeting are included in the notice and the nomination committee’s motivated opinion, published on EQT’s website. EQT AB’s Annual Shareholders’ Meeting is held on 1 June 2022. The proposal of Brooks Entwistle as new Board member is subject to relevant regulatory approvals.

The nomination committee comprises Conni Jonsson, Chairperson of the EQT AB Board and members appointed by the four largest shareholders in EQT AB: Jacob Wallenberg (Chairperson of the nomination committee), appointed by Investor AB, Harry Klagsbrun, appointed by Bark Partners AB, Shireesh Vasupalli, appointed by Lennart Blecher, Hans Sterte, appointed by Alecta.

Contact

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
Rickard Buch, Managing Director, Communications, +46 70 855 03 56
EQT Press Office, press@eqtpartners.com, +46 8 506 55 334

About EQT

EQT is a purpose-driven global investment organization focused on active ownership strategies. With a Nordic heritage and a global mindset, EQT has a track record of almost three decades of delivering consistent and attractive returns across multiple geographies, sectors and strategies. EQT has investment strategies covering all phases of a business’ development, from start-up to maturity. EQT today has EUR 77 billion in assets under management across 36 active funds within two business segments – Private Capital and Real Assets.

With its roots in the Wallenberg family’s entrepreneurial mindset and philosophy of long-term ownership, EQT is guided by a set of strong values and a distinct corporate culture. EQT manages and advises funds and vehicles that invest across the world with the mission to future-proof companies, generate attractive returns and make a positive impact with everything EQT does.

The EQT AB Group comprises EQT AB (publ) and its direct and indirect subsidiaries, which include general partners and fund managers of EQT funds as well as entities advising EQT funds. EQT has offices in 23 countries across Europe, Asia-Pacific and the Americas and has more than 1,300 employees.

Categories: People

Blackstone Announces Len Laufer, a Leader in Data Science and Technology across the Financial Services Industry, as Senior Advisor

Blackstone

New York, April 26, 2022 – Blackstone (NYSE: BX) today announced the appointment of Len Laufer, a pioneer in data science and long-time executive across the financial services industry, as a senior advisor. He will advise across Blackstone’s businesses, with a focus on Blackstone Growth (BXG), the firm’s growth equity investing platform.

Mr. Laufer brings a rare combination of experience as both a successful entrepreneur and Fortune 100 leader across industries. In 1997, he founded Argus Information and Advisory Services and grew the company over the next 15 years into a leading provider of information and analytical solutions to the payments industry. After selling the business in 2012, Mr. Laufer went on to lead JPMorgan Chase’s machine learning and data science efforts as Head of Intelligent Solutions. Most recently, he served as CEO of Cerberus Technology Solutions, the operating subsidiary of Cerberus Capital Management, which focused on the use of technology, data and artificial intelligence in investment activities and at the firm’s portfolio companies. Mr. Laufer also served as Co-Chairman of the Board for Alberstons Companies, one of the largest food and drug retailers in North America, until 2021.

Vini Letteri, Senior Managing Director and Head of Financial Services for Blackstone Growth, said: “Len’s breadth of experience and first-hand understanding of the challenges of scaling a business will be invaluable to our portfolio companies and their founders. All companies, regardless of their industry, are looking to better use technology to improve their business and protect against disruption. Len’s knowledge will be a real benefit as they face these challenges.”

Len Laufer added: “I applaud Blackstone’s emphasis on the importance of data and technology as both an investing theme and as an operational imperative for the companies across its portfolio. I look forward to working with the BXG team and others across the firm in these efforts.”

Mr. Laufer graduated cum laude with honors from Harvard College with an AB in Social Studies, and earned an MBA from the Wharton Business School at the University of Pennsylvania.

About Blackstone
Blackstone is the world’s largest alternative asset manager. We seek to create positive economic impact and long term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our $915 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, infrastructure, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com. Follow @blackstone on LinkedIn, Twitter, and Instagram.

Contact
Tom Clements
(646) 482-6088
Thomas.Clements@blackstone.com

Categories: People

Tags:

Cinven Appoints Julia Kahr as Partner and Head of North America

Cinven

International private equity firm Cinven today announces that it has appointed Julia Kahr as a Partner and Head of North America.  Based in New York, Julia will lead and oversee Cinven’s operations in North America.

Julia was most recently a Senior Managing Director at Blackstone, which she joined in 2004, leading investments in the Healthcare and Industrials sectors. Her significant expertise in the Healthcare Private Equity market specifically includes investments in market-leading businesses within the pharma services, medical devices and life sciences sectors.

Julia joins Cinven’s U.S. team, which has been involved in a number of companies in the Healthcare and Technology, Media and Telecommunications (TMT) sectors and has also supported the U.S.-based acquisitions for several of Cinven’s European portfolio companies.  Recent Cinven investments include BioAgilytix, a global bioanalytical services business; Nitel, a technology services provider; Drake Software, a provider of software for tax preparers; National Seating & Mobility, a provider of complex rehabilitation mobility and accessibility solutions; and Jaggaer, a global provider of procurement software for large and medium-sized enterprises.

Alex Leslie, Partner, who previously moved to New York to lead Cinven’s capabilities in the region, will return to London in September 2022 and remain an integral member of Cinven’s leadership team.

Stuart McAlpine, Managing Partner at Cinven, commented:

“Julia brings a wealth of experience and knowledge, especially of the global Healthcare sector and in the U.S. private equity market.  Her investing track record coupled with her leadership experience position Julia well to build on the success of Cinven’s sector – country matrix and lead its efforts in the U.S. market.  We are delighted Julia is joining the Cinven team and partnership.

“Alex has successfully built Cinven’s presence and led Cinven’s engagement in Healthcare and TMT in the U.S., over the past six years. During that time, he has built a talented Investment team that includes expertise across Capital Markets, Portfolio operational support and Investor Relations.”

Alex Leslie, Partner at Cinven, added:

“It has been a great privilege to establish Cinven’s business in North America and build its capabilities in the region over the last six years, especially in putting together such a talented and motivated team. It is pleasing to see those efforts start to deliver results, with a number of exciting Healthcare

and TMT investments. I am delighted to welcome Julia to Cinven and am thrilled to have found such a perfect successor to take the business on and lead the team in the next stage of growth.”

Commenting on her appointment, Julia Kahr, Partner and Head of North America at Cinven, said:

“I am excited to have the opportunity to join one of the oldest and most established European private equity firms with a truly unique culture and approach and lead its North American operations.

“Cinven’s investment strategy is differentiated by its culture and its sector / country / functional matrix.  Cinven’s success is underpinned by more than 40 years’ experience of investing internationally, specifically in the Healthcare and TMT sectors. I have been enormously impressed by the culture and the calibre of the Cinven team. Alex has done an excellent job leading Cinven’s U.S. team over the last six years, and I look forward to working with him and the rest of the team in building on their success.”

Categories: People

Johan Arvidsson appointed new CEO of Diab

Ratos

Johan Arvidsson has extensive experience from senior positions at Nolato. He is currently Executive Director and President of Nolato’s Industrial Solutions business area and part of the company’s management team. He will assume the position of CEO of Diab by October 2022 at the latest.

 

“We are delighted that Johan Arvidsson will be taking on the role as CEO of Diab. He is very knowledgeable about the industry and has extensive international experience and a track record as a strong leader. We believe that the next phase of Diab’s development should take place under new leadership. At the same time, we want to thank Tobias Hahn who, during his time as CEO, has developed and strengthened Diab as a company, primarily in the wind segment,” says Joakim Twetman, Chairman of the Board of Diab and President Business Area Industry, Ratos.

Per Magnusson, a Board member of Diab since 2018, has been appointed as interim CEO until Johan Arvidsson takes over.

“I very much look forward to leading Diab into the future. There are major changes taking place in the world that we need to take into consideration, and I am convinced that Diab, with its talented employees and world-class products, has a bright future ahead. I want to thank Ratos for the trust they have placed in me and look forward to getting started,” says Johan Arvidsson, incoming CEO of Diab.

About Diab
Diab is a global company that helps its customers with high strength, low weight structures through strong technical expertise, manufacturing and processing of core sandwich composite material. Diab’s high-performance core materials and solutions all over the world, for example in boats, vessels, aircraft and other means of transport and in wind turbines. The various core materials have unique combinations of characteristics such as low weight, high strength, insulation properties and chemical resistance. Diab has production units in Sweden, Italy, the US, China, Lithuania and Ecuador combined with 14 sales units around the world.

For further information:
Joakim Twetman, Chairman of the Board of Diab and President Business Area Industry, Ratos,
+46 70 339 16 66

Josefine Uppling, VP Communication, Ratos, +46 76 114 54 21

About Ratos
Ratos is a business group consisting of 13 companies divided into three business areas: Construction & Services, Consumer and Industry. In total 2020, the companies have approximately SEK 36 billion in sales. Our business concept is to develop companies headquartered in the Nordics that are or can become market leaders. We enable independent companies to excel by being part of something larger. People, leadership, culture and values are key focus areas for Ratos. Everything we do is based on Ratos’s core values: Simplicity, Speed in Execution and It’s All About People.

Categories: People

Johan Arvidsson appointed new CEO of Diab

Ratos

Johan Arvidsson has extensive experience from senior positions at Nolato. He is currently Executive Director and President of Nolato’s Industrial Solutions business area and part of the company’s management team. He will assume the position of CEO of Diab by October 2022 at the latest.

“We are delighted that Johan Arvidsson will be taking on the role as CEO of Diab. He is very knowledgeable about the industry and has extensive international experience and a track record as a strong leader. We believe that the next phase of Diab’s development should take place under new leadership. At the same time, we want to thank Tobias Hahn who, during his time as CEO, has developed and strengthened Diab as a company, primarily in the wind segment,” says Joakim Twetman, Chairman of the Board of Diab and President Business Area Industry, Ratos.

Per Magnusson, a Board member of Diab since 2018, has been appointed as interim CEO until Johan Arvidsson takes over.

“I very much look forward to leading Diab into the future. There are major changes taking place in the world that we need to take into consideration, and I am convinced that Diab, with its talented employees and world-class products, has a bright future ahead. I want to thank Ratos for the trust they have placed in me and look forward to getting started,” says Johan Arvidsson, incoming CEO of Diab.

About Diab
Diab is a global company that helps its customers with high strength, low weight structures through strong technical expertise, manufacturing and processing of core sandwich composite material. Diab’s high-performance core materials and solutions all over the world, for example in boats, vessels, aircraft and other means of transport and in wind turbines. The various core materials have unique combinations of characteristics such as low weight, high strength, insulation properties and chemical resistance. Diab has production units in Sweden, Italy, the US, China, Lithuania and Ecuador combined with 14 sales units around the world.

For further information:
Joakim Twetman, Chairman of the Board of Diab and President Business Area Industry, Ratos,
+46 70 339 16 66

Josefine Uppling, VP Communication, Ratos, +46 76 114 54 21

About Ratos
Ratos is a business group consisting of 13 companies divided into three business areas: Construction & Services, Consumer and Industry. In total 2020, the companies have approximately SEK 36 billion in sales. Our business concept is to develop companies headquartered in the Nordics that are or can become market leaders. We enable independent companies to excel by being part of something larger. People, leadership, culture and values are key focus areas for Ratos. Everything we do is based on Ratos’s core values: Simplicity, Speed in Execution and It’s All About People.

Categories: People

The Stephens Group Hires Four to Bolster Business Development, Investment and Operational Teams

Stephens Group

LITTLE ROCK, ARKANSAS – APRIL 14, 2022 –The Stephens Group, LLC (“The Stephens Group”), the private investment firm backed by the Witt Stephens and Elizabeth Campbell families, announced it has hired four new employees to bolster The Stephens Group’s business development, investment, and operational teams.

Ryan Morrow was hired as a Principal to focus on technology investing and is responsible for all aspects of deal sourcing, evaluation, and execution of new technology-focused investments as well as partnering with portfolio company management to execute strategic and operational initiatives. Previously, Mr. Morrow spent nearly a decade s in various leadership roles in venture capital and private equity backed technology companies. Most recently, he was the CFO of Ungerboeck, a vertical SaaS provider to the events industry, and Apptegy, a high growth EdTech SaaS provider. Ryan began his career in both buyside and sellside equity research and holds the Chartered Financial Analyst designation.

Callie Blankenau was hired as a Senior Associate to assist with the business development efforts and is actively involved in sourcing and originating new transactions on behalf of The Stephens Group. Previously, Mrs. Blankenau spent four and a half years as an Associate at ORIX in the Private Equity Solutions group, a generalist lower middle market private equity, and Energy Capital, an energy focused flexible capital provider.

Lindsey Joseph was hired as a Senior Associate to advise the firm’s portfolio companies on strategies to improve operational performance. Previously, Mrs. Joseph spent seven years as a consultant at The Boston Consulting Group (BCG), Accenture Strategy and Kurt Salmon serving Fortune 500 clients. Through her time in consulting, Mrs. Joseph has built particular expertise in the change management, ecommerce, data analytics and supply chain network optimization space.

Karlton Haney was hired as an analyst to assist the team’s investment and operational efforts.  He conducts financial analysis, due diligence and industry research to evaluate new investment opportunities and works on the operations team, supporting strategic priorities for existing portfolio companies. Previously, Mr. Haney spent a year as a financial analyst in Walmart’s Accounting and Finance Development Program.

Witt Stephens, Chairman and CEO of The Stephens Group, said, “By investing in our people and expanding our functional capabilities over the last few years, we have seen measurable improvements in our ability to source and execute on new opportunities as well as create value across the existing portfolio. We are excited about strengthening our team across both our investment and functional disciplines.”

ABOUT THE STEPHENS GROUP, LLC

The Stephens Group, LLC is a private investment firm that partners with talented management teams to help build valuable businesses. Backed by the resources of the Witt Stephens and Elizabeth Campbell families, the firm combines the operational expertise of a private equity firm with the flexibility provided by long-term capital. With nearly $2 billion of private equity assets under management, the firm has a long history of providing informed, sophisticated expertise and working with owners and managers to help them successfully achieve their strategic visions and build long-term value. Since 2006, The Stephens Group has invested in 49 companies, targeting investments in industries across the U.S., including industrial and commercial products and services, specialty distribution, B2B food, technology infrastructure and tech-enabled services.

CONTACT:

Allie Laborde
Principal, Business Development
The Stephens Group, LLC
pressreleases@stephensgroup.com
501.377.3401

Categories: People

3i announces six senior promotions to Partner in its Private Equity team

3I

3i Group plc (“3i”) is pleased to announce the promotions of Andreas Gold, Rupert Howard, Rahul Lulla, Nikhil Patel, Bastiaan Peer and David Stephens to Partner.

Andreas Gold joined 3i in 2007 and is based in 3i’s German Private Equity team.

Rupert Howard is in 3i’s Private Equity UK team which he joined in 2018.

Rahul Lulla joined 3i in 2012 and works in 3i’s Private Equity team in North America.

Nikhil Patel is in the North American Private Equity team and joined 3i in 2016.

Bastiaan Peer joined 3i in 2014 and works in the Benelux Private Equity team.

David Stephens joined 3i in 2011 and is in the UK Private Equity team.

Pieter de Jong and Peter Wirtz, Co-Heads of Private Equity, 3i, said: “Andreas, Rupert, Rahul, Nikhil, Bastiaan and David have each made an excellent contribution to our Private Equity business. They demonstrate the strength and depth of our team across Europe and North America and we congratulate them on their well-deserved promotions.”

 

-ends-

Download this press release  

 

 

For further information, contact:

 

3i Group plc

Kathryn van der Kroft

Media enquiries

 

Silvia Santoro

Shareholder enquiries

  

 

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

 

Notes to editors:

About 3i Group

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com

Categories: People

Alliance Pharma Appoints Patrick Bennett as Chief Executive Officer

Ampersand

MALVERN, Pa., April 11, 2022 /PRNewswire/ — Alliance Pharma, a leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, announces that Patrick Bennett has been named Chief Executive Officer. Bennett has more than 30 years of experience in the industry, including 25 years in leadership roles at various bioanalytical contract research organizations, most recently as Vice President, Strategy and Development at PPD Laboratories. Prior to PPD, Bennett served as the Director of Global Strategic Marketing at ThermoFisher Scientific, and at various executive level positions with Tandem Labs. Frank Li, Founder of Alliance Pharma, is transitioning leadership to Bennett but will remain a key member of the Alliance team and serve as its President and on its Board of Directors. Throughout his career, Patrick has developed broad bioanalytical expertise and established a strong reputation as a leader and innovator in laboratory operations. In his most recent roles, he established biomarker, cell and gene therapy operations, and a state-of-the-art bioanalytical lab in China.

Patrick Bennett CEO Announcement“Alliance will execute an aggressive global growth strategy, and there is no one more timely, skilled, or better suited to lead Alliance than Pat. His operational expertise, global experience, long-term relationship-driven nature, and exceptional communication skills are a perfect fit for Alliance,” explained Dave Patteson, Chairman of the Board at Alliance and a Partner at Ampersand, Alliance’s principal owner.

“Frank Li has founded, built, grown and led an exceptional bioanalytical service offering and team of premier scientists, serving the pharma/biopharma industry. Our vision is to build upon this knowledge and experience, allowing Alliance to fulfill its mission as a complete global bioanalytical service provider for all drug modalities,” Patrick Bennett, New CEO of Alliance Pharma, commented.

About Alliance Pharma

Founded in 2008, Alliance is a contract research organization (CRO) in Malvern, PA just outside of Philadelphia that specializes in advanced bioanalytical research services for both small and large molecule drugs, as well as drug metabolism studies to support pharmaceutical and biotechnology companies’ drug discovery and development programs. Alliance’s mission is to build a trusted partnership with our clients to support their successful drug development programs. Our business philosophy is based on a foundation of trust, professional ethics, scientific excellence and regulatory compliance. http://www.alliancepharmaco.com/

About Ampersand Capital Partners

Founded in 1988, Ampersand is a middle market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors. Additional information about Ampersand is available at ampersandcapital.com.

Categories: People